Sanofi is halting the phase 3 MOBILIZE trial evaluating riliprubart for chronic inflammatory demyelinating polyneuropathy due to lack of efficacy.

An expert interview explores the scientific necessity of patient experience data in amyotrophic lateral sclerosis drug ...

Metabolomic aging could serve as a biomarker to identify patients at an increased risk for incident dementia before clinical symptoms emerge.

Well-being metrics like health and education among children declined across the country between 2019 and 2024.

Sleep difficulties are associated with psychological well-being among adults and older adults, with a stronger association among women.

The FDA has approved the oral antiviral Xocova (ensitrelvir) for postexposure prophylaxis of COVID-19 in adults and adolescents.

People with later chronotypes often report worse mental health, partially explained by greater reported loneliness.

A new tool may help support optometrist and ophthalmologist decisions as they develop care plans for adolescents with amblyopia.

Pure autonomic failure may serve as a prodromal manifestation of Parkinson disease, Lewy body dementia, and multiple system atrophy.

Cardiovascular disease risk factor associations with social determinants of health vary significantly by nativity among Black US adults.

Metastatic progression reduction is associated with GLP-1 RA initiation after cancer diagnosis across multiple solid tumors.

RFK Jr wants the government to have access to medical records across the country in a quest to connect vaccines and autism spectrum disorder.